Smooth Drug Development March 2025 News Release

Monthly News – March 2025

At Smooth Drug Development, we are excited to share the latest updates and achievements from March 2025:

New Projects

We are delighted to announce several new collaborations:

• Agreement signed with a Chinese client for a Phase III study with human immunoglobulin to be conducted in Turkey.
• Contract signed with a Hungarian client for medical writing services.
• Contract prepared for medical writing support in a Phase III study with Sertaconazole.
• Successfully won a tender for a full-service BE trial with Isotretinoin.

Clinical and Scientific Departments News:

Our clinical teams continue to deliver outstanding progress:

• Enrollment completed for a BE study in oncology.
• CTA submission in Turkey completed and three site selection visits conducted for the human immunoglobulin trial.
• First patients included in the Cetirizine trial.
• 127 patients enrolled in the Pembrolizumab trial.

Business Development News:

Our Business Development team has been actively engaging in discussions, collaborations, and attending key conferences:

• Attended BioChina Conference (March 13-15) in Suzhou, China.